5-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}-1,3-oxazole-4-carboxylic acid

Catalog No. :
ACKXMU546
CAS No. :
1252657-86-5
Molecular Formula :
C14H20N2O5
Molecular Weight :
296.32

IUPAC Name:5-(1-(tert-butoxycarbonyl)piperidin-4-yl)oxazole-4-carboxylic acid

5-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}-1,3-oxazole-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$298.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}-1,3-oxazole-4-carboxylic acid
IUPAC Name5-(1-(tert-butoxycarbonyl)piperidin-4-yl)oxazole-4-carboxylic acid
MDL No.MFCD30497637
Molecular FormulaC14H20N2O5
Molecular Weight296.32
SMILESO=C(C1=C(C2CCN(C(OC(C)(C)C)=O)CC2)OC=N1)O
InChI KeyIKDSOZSAZOWWKW-UHFFFAOYSA-N
Synonym5-[1-(tert-Butoxycarbonyl)piperidin-4-yl]-1,3-oxazole-4-carboxylic acid;1-Piperidinecarboxylic acid, 4-(4-carboxy-5-oxazolyl)-, 1-(1,1-dimethylethyl) ester;5-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}-1,3-oxazole-4-carboxylic acid5-{1-[(tert-Butoxy)carbonyl]piperidin-4-yl}-1,3-oxazol-4-carboxylic? acid;5-{1-(tert-Butoxy)carbonylpiperidin-4-yl}-1,3-oxazol-4-carboxylic acid5-{1-(tert-butoxy)carbonylpiperidin-4-yl}-1,3-oxazol-4-carboxylic? acid;5-(1-(Tert-butoxycarbonyl)piperidin-4-yl)oxazole-4-carboxylic acid;5-(1-Boc-4-piperidyl)oxazole-4-carboxylic Acid
CAS No.1252657-86-5

Synthetic Route by SureRoute

1. ACKXMU546 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKXMU546 route product structure diagram
    ACKXMU5461252657-86-5
Inquiry

2. ACKXMU546 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKXMU546 route product structure diagram
    ACKXMU5461252657-86-5
Inquiry

Comments (0)